Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Latticon Antibody Therapeutics, Inc
- Target Recruit Count
- 150
- Registration Number
- NCT06277219
- Locations
- 🇺🇸
D&H Cancer Research Center, Margate, Florida, United States
🇺🇸Huntsman Cancer Institute, Salt Lake City, Utah, United States
🇨🇳Cancer Hospital of Shandong First Medical University, Jinan, Shandong, China
News
No news found